Areas of Focus
- Anti-inflammatory and Immunopharmacology
- Hepatic Pharmacology
Work Experience
- 2019-07 to 2021-05 - National Institutes of Health, USA - Assistant Researcher
- 2016-07 to 2019-06 - National Institutes of Health, USA - Postdoctoral Researcher
- 2013-09 to 2016-06 - Anhui Medical University - PhD
- 2010-09 to 2013-06 - Anhui Medical University - Master's
Academic Background & Achievements
- 2013-09 to 2016-06 PhD: Anhui Medical University
- 2010-09 to 2013-06 Master's: Anhui Medical University
Publications
- Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells, Yong He, 2024
- Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets, Yong He, 2023
- MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression, Yong He, 2023
- Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IjBf target genes in hepatocytes, Yong He, 2021
- MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types, Yong He, 2021
- Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis, Yong He, 2021
- Immunopathobiology and therapeutic targets related to cytokines in liver diseases, Yong He, 2020
- MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases, Yong He, 2020
- MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes, Yong He, 2019
- Hepatic Mitochondrial DNA/Toll-Like Receptor 9/MicroRNA-223 Forms a Negative Feedback Loop to Limit Neutrophil Overactivation and Acetaminophen Hepatotoxicity in Mice, Yong He, 2017
